MTE #36 - Cholangiocarcinoma in PSC: Screening, Diagnosis and Management
MTE to understand the best strategies for surveillance and management of hepatobiliary cancers in patients with PSC particularly cholangiocarcinoma
MTE to understand the best strategies for surveillance and management of hepatobiliary cancers in patients with PSC particularly cholangiocarcinoma
Faculty will discuss risk of HCC in emerging at-risk populations for HCC, including patients with MASLD and those who are post-SVR. We will specifically address the controversy regarding HCC risk and benefits of HCC surveillance in patients with advanced
Review common benign liver lesions and their management.
The PharmD is an integral part the multidisciplinary team. In this session you will gain insight from a PharmD on their unique role as a member of the Hepatology and Transplant team in improving patient outcomes.
Andrea Gossard is a Certified Nurse Practitioner, an Associate Professor of Medicine and a Director of NP PA practice at Mayo Clinic in Rochester, Minnesota. Her clinical and research interests are focused on the diagnosis and management of cholestatic and autoimme liver diseases including Primary Sclerosing Cholangitis, Primary Biliary Cholangitis, and Autoimmune Hepatitis. She is an Associate Fellow of the American Association for the Study of Liver Disease (AASLD) and Chair of the Hepatology Associates Special Interest Group. In addition, she is a member of the American Gastroenterology Association (AGA) and the American College of Gastroenterology (ACG).
Andrea was one of the founding members of Gastroenterology and Hepatology for Advanced Practice Providers (GHAPP), an association led by Advanced Practice Providers (APPs) and committed to education and professional development of APPs. She remains on the Board of Trustees.
The American Association for the Study of Liver Diseases (AASLD) acknowledges the important open letter by Rainbows in Gastro...
Steatotic liver disease (SLD) is the new overarching term with metabolic dysfunction-associated steatotic liver disease (MASLD)...